PD-1 and PD-L1 expression on tumor-infiltrating immune cells was also higher in BRCA-mutated tumors, but no significant difference was observed in PD-L1 expression on tumor cells or the number of B cells [55]. The gene discussed is PDCD1; the disease is neoplasm.